VIR
NASDAQ
$9.23
Vir Biotechnology Inc (VIR)
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $21.56 (+133.59%)
Market Cap
$1.55B
Free Cash Flow Yield
-29.02%
Beta (5Y)
1.52
Price Chart
Valuation
Market Cap$1.55B
Forward P/E4.27
P/S24.75
P/B1.97
Profitability
Total Revenue (TTM)$65M
Gross Profit (TTM)-$371M
EBITDA-$460M
Operating Margin459241%
EPS-$3.06
Financial Health
Free Cash Flow Yield-29.02%
Growth & Risk
EPS 5Y CAGR-0.01%
Revenue 5Y CAGR-2.05%
FCF 5Y CAGR+13.57%
Beta (5Y)1.52
Sharpe Ratio1.03